Clinical Trial Update: PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM) [NA]

View source ↗

Summary

A recruiting clinical trial evaluating PET/MR imaging with the CXCR4-targeting tracer [68Ga]Ga-PentixaFor versus standard of care for initial staging and follow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• [68Ga]Ga-PentixaFor (CXCR4) (pentixafor)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Multiple Myeloma | NA | Status: RECRUITING